150 related articles for article (PubMed ID: 28406995)
1. Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
Tsunaka M; Shinki H; Koyama T
PLoS One; 2017; 12(4):e0175765. PubMed ID: 28406995
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant effects of retinoic acids on leukemia cells.
Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
[TBL] [Abstract][Full Text] [Related]
3. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
[TBL] [Abstract][Full Text] [Related]
4. Histones Induce the Procoagulant Phenotype of Endothelial Cells through Tissue Factor Up-Regulation and Thrombomodulin Down-Regulation.
Kim JE; Yoo HJ; Gu JY; Kim HK
PLoS One; 2016; 11(6):e0156763. PubMed ID: 27258428
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
López-Pedrera C; Barbarroja N; Buendía P; Torres A; Dorado G; Velasco F
Haematologica; 2004 Mar; 89(3):286-95. PubMed ID: 15020266
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.
Tormoen GW; Recht O; Gruber A; Levine RL; McCarty OJ
Phys Biol; 2013 Oct; 10(5):056010. PubMed ID: 24104188
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells.
Koyama T; Hirosawa S; Kawamata N; Tohda S; Aoki N
Blood; 1994 Nov; 84(9):3001-9. PubMed ID: 7949172
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells.
Shibakura M; Koyama T; Saito T; Shudo K; Miyasaka N; Kamiyama R; Hirosawa S
Blood; 1997 Aug; 90(4):1545-51. PubMed ID: 9269772
[TBL] [Abstract][Full Text] [Related]
10. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.
Langer F; Amirkhosravi A; Loges S; Meyer T; Eifrig B; Hossfeld DK; Fiedler W; Francis JL
Thromb Haemost; 2004 Nov; 92(5):1136-46. PubMed ID: 15543344
[TBL] [Abstract][Full Text] [Related]
11. [Expression of alternatively spliced human tissue factor in acute leukemia cells].
Fang Y; Cai JY; Zhong JH; Zhong H; Wang HR; Chen FY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):288-92. PubMed ID: 21518473
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta.
Uruno A; Noguchi N; Matsuda K; Nata K; Yoshikawa T; Chikamatsu Y; Kagechika H; Harigae H; Ito S; Okamoto H; Sugawara A
J Leukoc Biol; 2011 Aug; 90(2):235-47. PubMed ID: 21393419
[TBL] [Abstract][Full Text] [Related]
13. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
[TBL] [Abstract][Full Text] [Related]
14. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant effects of synthetic retinoids.
Koyama T; Shibakura M
Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin.
Song JH; Kim SH; Kim HJ; Hwang SY; Kim TS
Int J Oncol; 2008 Apr; 32(4):931-6. PubMed ID: 18360721
[TBL] [Abstract][Full Text] [Related]
17. The influence of joint application of arsenic trioxide and daunorubicin on primary acute promyelocytic leukaemia cells and apoptosis and blood coagulation of cell strain.
Zhang X; Qin N; Chen X; Guo S
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1075-8. PubMed ID: 26051726
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy.
Jacobsen C; Oechsle K; Hauschild J; Steinemann G; Spath B; Bokemeyer C; Ruf W; Honecker F; Langer F
Thromb Res; 2015 Sep; 136(3):673-81. PubMed ID: 26205155
[TBL] [Abstract][Full Text] [Related]
19. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
20. n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation.
Picou F; Debeissat C; Bourgeais J; Gallay N; Ferrié E; Foucault A; Ravalet N; Maciejewski A; Vallet N; Ducrocq E; Haddaoui L; Domenech J; Hérault O; Gyan E
Pharmacol Res; 2018 Oct; 136():45-55. PubMed ID: 30142422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
